About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The eHealth Diabetes Remission Trial - Pilot Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04805996

The eHealth Diabetes Remission Trial - Pilot Study

Ten study participants will consume a low-calorie total diet replacement for 12 weeks, have a 6-week food reintroduction phase (week 13-18) and continue with the weight loss maintenance phase until th...

Lead sponsor: Julia Otten•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Julia Otten

Collaborators

Region Västerbotten

Age

20 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Type 2 diabetes with diabetes duration 0 to 6 years
•BMI 27-45 kg/m2
•Owning a smartphone
•HbA1c 43-107 mmol/mol during the past 12 months (48-107 mmol/mol without blood sugar lowering medication)

Exclusion Criteria

•Insulin treatment
•Weight loss 5 kg or more during the past 6 months
•Treatment with weight loss medication
•Diagnosed eating disorder
•eGFR \< 30 ml/min/1.73m2
•Substance abuse
•Cancer
•Myocardial infarction during the past 6 months
•Severe heart failure
•Pregnancy

Related studies

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

NCT07659535 · Type 2 Diabetes

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

RECRUITINGPhase 3

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes

NCT06319716 · Type 2 Diabetes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 1, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment10

Start dateMar 2021

Last updatedFeb 1, 2022

Condition

Type 2 Diabetes

Locations shown

Department of Public Health and Clinical Medicine, Medicine

Umeå

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 1, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions